Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$236,887
+$27,693 QoQ
Shares Held
1,875
+24.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,825
of 2,275 holders
Holding Since
Dec 2021
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SFMG, LLC holds $17,137,338 across 10 Drug Manufacturers - General names. GILD ranks #9 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
121,108 | $5,805,917 | |
| 2 | LLY |
ELI LILLY & Co
|
3,421 | $4,103,250 | |
| 3 | JNJ |
Johnson & Johnson
|
14,871 | $3,776,787 | |
| 4 | ABBV |
AbbVie Inc.
|
5,732 | $1,442,400 | |
| 5 | AMGN |
Amgen Inc
|
1,884 | $682,234 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,704 | $347,464 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,723 | $272,139 | |
| 8 | AZN |
Astrazeneca PLC
|
1,394 | $264,330 |
All Filings in GILD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $236,887 | 1,875 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $209,194 | 1,501 | Shares | Sole | 2026-05-12 | |
| 2023-06-30 | $242,385 | 3,145 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $264,010 | 3,182 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $270,427 | 3,150 | Shares | Sole | 2023-01-25 | |
| 2022-06-30 | $444,475 | 7,191 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $393,142 | 6,613 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $529,109 | 7,287 | Shares | Sole | 2022-01-31 | |
| No filing history on record for this holder in this stock. | ||||||